Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-08

Clinical Trial Update: Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients [NA]

View source ↗

Summary

A Mayo Clinic–sponsored clinical trial evaluating prehabilitation for patients with advanced ovarian, fallopian tube, or primary peritoneal cancer (Stage IIIC–I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Advanced Ovarian Carcinoma, Stage IIIC Fallopian Tube Cancer AJCC v8 | NA | Status: COMPLETED